The authors regret that there are additional errors in the original manuscript that were not noted in the first correction notice.

[Table 1](#tab1){ref-type="table"} is incorrect in the original manuscript as a number of citations were incorrectly numbered and some PDB IDs were omitted from the original table. The correct table is displayed below.

###### Summary of the currently available HIF structures

  Structure                                                        Structure details                                         PDB ID                                         Ref.
  ---------------------------------------------------------------- --------------------------------------------------------- ---------------------------------------------- ------
  HIF dimers                                                       HIF1α/ARNT                                                [4H6J](4H6J)                                   33
  HIF2α/ARNT/co-activator complex                                  [4PKY](4PKY)                                              34                                             
  HIF2α/ARNT complex                                               [3F1P](3F1P)                                              35                                             
  HIF2α/ARNT complex with an artificial ligand bound               [3F1O](3F1O)                                                                                             
  HIF2α/ARNT complex                                               [4ZP4](4ZP4)                                              55                                             
  HIF2α/ARNT complex with a benzoxadiazole ligand bound            [4GS9](4GS9), ; [4GHI](4GHI)                              36 and 37                                      
  HIF2α-ARNT bound to PT2399                                       [5UFP](5UFP)                                              38                                             
  HIF2α-ARNT bound to PT2385                                       [5TBM](5TBM)                                              39                                             
  HIF2α-ARNT PAS domain bound to tetrazole containing antagonist   [4XT2](4XT2)                                              40                                             
  HIF2α-ARNT complex bound to proflavin                            [4ZPH](4ZPH)                                              55                                             
  HIF2α-ARNT complex with HRE DNA                                  [4ZPK](4ZPK)                                              55                                             
  HIF2α-ARNT bound to benzoxadiazole antagonist                    [4ZQD](4ZQD)                                              55                                             
  HIF1α-ARNT complex with HRE DNA                                  [4ZPR](4ZPR)                                              55                                             
  HIF2α-ARNT bound to benzoxadiazole antagonist                    [4ZQD](4ZQD)                                              55                                             
  HIF2α-ARNT bound to THS017/THS020                                [3H7W](3H7W), ; [3H82](3H82)                              41                                             
  HIF2α-ARNT complex with ethylene glycol                          [3F1N](3F1N)                                              35                                             
  HIF-FIH complexes                                                FIH in complex with HIF-1α                                [1H2K](1H2K), ; [1H2L](1H2L), ; [1H2M](1H2M)   42
  FIH (D201E) complex with HIF-1α and α-ketoglutarate              [5JWP](5JWP)                                              43                                             
  [3D8C](3D8C), ; [2ILM](2ILM)                                     44                                                                                                       
  HIF-PHD complexes                                                PHD2 in complex with 2OG and HIF-1α CODD                  [5L9B](5L9B), ; [5L9V](5L9V), ; [5LA9](5LA9)   45
  [5LAS](5LAS)                                                                                                                                                              
  PHD2 in complex with NOG and HIF-1α                              [3HQR](3HQR)                                              133                                            
  vHL-HIF complexes                                                vHL/elongin/B-elongin/C-elongin complex bound to HIF-1α   [4AJY](4AJY)                                   46
  [1LQB](1LQB)                                                     47                                                                                                       
  [1LM8](1LM8)                                                     48                                                                                                       
  HIF-1α complexes                                                 NMR structures of HIF-1a bound to p300                    [1L3E](1L3E)                                   62
  [1L8C](1L8C)                                                     63                                                                                                       

Ref. 88 is incorrect in the original manuscript the correct citation is: J. S. Isaacs, Y.-J. Jung, E. G. Mimnaugh, A. Martinez, F. Cuttitta and L. M. Neckers, *J. Biol. Chem.*, 2002, **277**, 29936--29944.

Ref. 89 is incorrect in the original manuscript the correct citation is: E. Hur, H.-H. Kim, S. M. Choi, J. H. Kim, S. Yim, H. J. Kwon, Y. Choi, D. K. Kim, M.-O. Lee and H. Park, *Mol. Pharmacol.*, 2002, **62**, 975--982.

Ref. 99 is incorrect in the original manuscript the correct citation is: S. Kaluz, M. Kaluzová and E. J. Stanbridge, *Mol. Cell. Biol.*, 2006, **26**, 5895--5907.

[Table 2](#tab2){ref-type="table"} is also incorrect as a number of citations were incorrectly numbered. The correct table is displayed below.

###### Selected examples of HIF modulators. Error are given where available

  Ligand                   Target                      Potency                     Ref.
  ------------------------ --------------------------- --------------------------- ------------
  EZN-2698                 mRNA                        IC~50~ = 1--5 nM            75
  Topotecan                Topoisomerase I             IC~50~ = 11 ± 1.3 μM        76
  EZN-2208                 Topoisomerase I             IC~50~ = 0.5 ± 0.3 μM       78
  Digoxin                  HIF-1α protein expression   IC~50~ = 50 nM              79
  PX-478                   HIF-1α protein expression   IC~50~ = 20 ± 2 μM          80
  DMOG                     PHD2                        IC~50~ = 9.3 μM             82
  FG-2216                  PHD2                        IC~50~ = 0.3 μM             85
  Geldanamycin             HSP90                       *K* ~d~ = 1.21 μM           88
  Ganete spib              HSP90                       IC~50~ = 4 nM               90
  Echinomycin              HRE                         IC~50~ = 1.2 nM             96
  Acriflavine              HIF-1α/β                    IC~50~ = 1 μM               101
  Chetomin                 Zinc ejection               IC~50~ = 6.8 μM             32
  Ninhydrin                Zinc ejection               IC~50~ = 1.93 ± 0.97 μM     104
  KCN-1                    HIF-1α/p300                 IC~50~ = 0.65 ± 0.09 μM     105
  KG548                    ARNT/TACC3                  IC~50~ = 25 μM              109
  KHS101                   ARNT                        IC~50~ \< 5 μM              109
  cyclo-CLLFVY             HIF-1α/β                    *K* ~d~ = 124 (± 23) nM     112
  Phage display peptides   p300                        *K* ~d~ = 20.67 (± 23) μM   65
  Phage display Affimers   p300                        *K* ~d~ = 157 nM            65
  HBS peptide helix 2      p300                        *K* ~d~ = 420 nM            120
  HBS peptide helix 3      p300                        *K* ~d~ = 690 ± 25 nM       69
  Oligoamide 1             p300                        IC~50~ = 9.2 μM             108
  OHM-1                    p300                        *K* ~d~ = 420 nM            70 and 129

Ref. 133 is incomplete in the original manuscript. The correct citation should be: R. Chowdhury, M. A. McDonough, J. Mecinović, C. Loenarz, E. Flashman, K. S. Hewitson, C. Domene and C. J. Schofield, *Structure*, 2009, **17**, 981--989.

The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
